openPR Logo
Press release

Breast Cancer Diagnostics Market to Reach USD 12.45 Billion by 2035, Driven by Advanced Testing Technologies

07-02-2025 09:26 AM CET | Health & Medicine

Press release from: Fact.MR Market Research

Breast Cancer Diagnostics Market

Breast Cancer Diagnostics Market

The global breast cancer diagnostics market is projected to grow from USD 5,977 million in 2025 to USD 12,451 million by 2035, expanding at a robust CAGR of 6.9% over the forecast period.

This comprehensive market expansion is driven by rising demand for early, accurate detection methods including mammography, 3D tomosynthesis, ultrasound, MRI, liquid biopsies, BRCA testing, and other advanced diagnostic tools. The increasing prevalence of breast cancer cases worldwide continues to underscore the urgency for reliable and accessible diagnostics.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=55

Key Takeaways from Market Study:

The global breast cancer diagnostics market is projected to reach USD 12.45 billion by 2035.
The market is expected to grow at a CAGR of 6.9% from 2025 to 2035
The U.S. market is anticipated to expand at a CAGR of 7.4% during the forecast period.
Imaging diagnostics account for over 50% of market share and are growing at a CAGR of 6.7%.
Hospitals and associated labs dominate the end-user segment with around 51% market share
Genomic tests such as BRCA are expected to maintain strong demand
Liquid biopsy tests are projected to grow at a CAGR of over 9% through 2033.
The average cost of BRCA testing exceeds USD 3,000, posing a barrier in low-income regions.

Leading Players Driving Innovation in the Breast Cancer Diagnostics Market:

Hologic, Inc.; Siemens Healthineers AG; GE Healthcare; Becton, Dickinson and Company (BD); Philips Healthcare; Fujifilm Holdings Corporation; Thermo Fisher Scientific; Roche Diagnostics; Abbott Laboratories; Agilent Technologies, Inc.; Other Prominent Players.

Key Market Drivers:

A steady rise in breast cancer incidence has fueled demand for early-stage diagnostic solutions. Technological advancements such as AI-enhanced imaging, liquid biopsy platforms, and molecular diagnostics are transforming the landscape.

Integration of artificial intelligence in imaging tools is streamlining diagnosis, enhancing detection accuracy, and reducing turnaround time. Additionally, the emergence of next-generation sequencing and blood-based biomarker tests is enabling precision medicine approaches across the care continuum.

Segment Insights:

Imaging tests such as mammography, ultrasound, MRI, and PET dominate the diagnostic landscape, accounting for approximately 53% of the market share. This segment is projected to grow at a CAGR of 6.7% from 2025 to 2035, fueled by increasing adoption of advanced modalities and government-supported screening programs.

Hospitals and associated laboratories are the leading end-user segment, representing over 51% of revenue share in 2025, driven by their integrated infrastructure and multidisciplinary care capabilities.

Breast Cancer Diagnostics Market News:

Roche unveiled the AI-powered digital pathology solutions' commercialization enhancing cancer detection accuracy in October 2023.

The Federal Drug Administration (FDA) licensed a liquid biopsy test based on ctDNA in September 2023 for non-invasive breast cancer screening.

Browse Full Report: https://www.factmr.com/report/55/breast-cancer-diagnostics-market

More Valuable Insights on Offer:

Fact.MR, in its new offering, presents an unbiased analysis of the global Breast cancer diagnostics markets, presenting historical data for 2020 to 2024 and forecast statistics for 2025 to 2035.

The breast cancer diagnostics market is segmented by cancer type into ductal carcinoma in situ, HER2-positive breast cancer, invasive ductal carcinoma, invasive lobular carcinoma, and triple-negative breast cancer. Based on cancer stage, it includes stage 0 to stage 4. By grade, the classification includes grade 1, grade 2, and grade 3 tumors.

The market is categorized by test type into imaging tests (mammography, ultrasound, MRI, PET), biopsy-based tests (FNAB, CNB, surgical biopsy, liquid biopsy), genomic and molecular diagnostic tests (HER2, BRCA, hormone receptor testing, NGS), and blood-based tests (tumor markers and cfDNA).

End users include hospitals & clinics, diagnostic centers, academic & research institutes, ambulatory care centers, and pharmaceutical & biotechnology companies. Geographically, the market is segmented into North America, Latin America, Western and Eastern Europe, East Asia, South Asia & Pacific, and the Middle East & Africa.

Check out More Related Studies Published by Fact.MR Research:

Breast Imaging Technologies Market - https://www.factmr.com/report/breast-imaging-technologies-market

Cancer Profiling Market - https://www.factmr.com/report/358/cancer-profiling-market

Oncology Molecular Diagnostics Market - https://www.factmr.com/report/oncology-molecular-diagnostic-market

Cancer Biomarkers Market - https://www.factmr.com/report/4587/cancer-biomarkers-market

Anti-cancer Drugs Market - https://www.factmr.com/report/4350/anticancer-drugs-market

Contact Us:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog

About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Breast Cancer Diagnostics Market to Reach USD 12.45 Billion by 2035, Driven by Advanced Testing Technologies here

News-ID: 4089193 • Views:

More Releases from Fact.MR Market Research

Undecylenic Acid Market Is Expected To Grow At A CAGR Of 4% During The Forecast Period
Undecylenic Acid Market Is Expected To Grow At A CAGR Of 4% During The Forecast …
Undecylenic acid, an unsaturated fatty acid derived from castor oil, is recognized for its antifungal properties. It is widely used in medical treatments for skin infections, as well as in the production of cosmetics and personal care products. The market is projected to witness higher single-digit growth globally during the forecast period, with regions like North America and Europe leading in volume, while the Middle East and Africa (MEA) are
Whey Cheese Market to Reach USD 21.6 Billion by 2035 Amid Rising Demand for Functional Dairy Ingredients
Whey Cheese Market to Reach USD 21.6 Billion by 2035 Amid Rising Demand for Func …
The global whey cheese market is witnessing remarkable growth, driven by increasing consumer preference for protein-rich, functional, and sustainable dairy products. According to recent research, the market is expected to reach USD 21.6 billion by 2035, up from USD 10.5 billion in 2024, marking a robust compound annual growth rate (CAGR) of 6.8% during the forecast period from 2025 to 2035. Rising Demand for Functional and Protein-Rich Foods Fuels Market Expansion The
Enzyme-Enhanced Ingredients Market to Reach USD 11,657 Million by 2035, Driven by Innovation in Food and Beverage Applications
Enzyme-Enhanced Ingredients Market to Reach USD 11,657 Million by 2035, Driven b …
The global enzyme-enhanced ingredients market is poised for remarkable growth, with the industry projected to reach USD 11,657 million by 2035, up from USD 5,955 million in 2024. This expansion is expected to occur at a robust compound annual growth rate (CAGR) of 6.5% between 2025 and 2035. The surge in demand is primarily driven by the rising adoption of enzyme-based solutions across food, beverage, and nutraceutical industries, alongside an
Glycine Market Set to Reach USD 2,825.8 Million by 2035, Driven by Expanding Applications in Pharmaceuticals, Food, and Cosmetics
Glycine Market Set to Reach USD 2,825.8 Million by 2035, Driven by Expanding App …
The global glycine market is poised for remarkable growth over the next decade, with market value projected to surge from USD 1,356.4 million in 2024 to USD 2,825.8 million by 2035. During the forecast period from 2025 to 2035, the industry is expected to expand at a robust CAGR of 6.9%, reflecting the increasing demand for this versatile amino acid across multiple end-use sectors. Glycine, the simplest amino acid, is

All 5 Releases


More Releases for Breast

Breast Health Monitoring App Market to Witness a Pronounce Growth during 2024-20 …
The latest market intelligence report published by WMR with the title "Global Breast Health Monitoring App Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Healthcare and Pharmaceuticals industry. The report provides demand analysis, industry insights, competitive intelligence, and customer database. The Research report on Breast Health Monitoring App Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y
Primary Breast Cancer Survivor Phil Alderson Shines Light on Male Breast Cancer …
FOR IMMEDIATE RELEASE Primary Breast Cancer Survivor Phil Alderson Shines Light on Male Breast Cancer During Breast Cancer Awareness Month Liverpool, UK - October, 2023 - Phil Alderson, a primary survivor of male breast cancer, is taking bold steps this Breast Cancer Awareness Month to raise awareness of this often overlooked aspect of the disease. With a homemade cardboard sign that reads "Check Your Pecks," Phil has taken to the streets of
Breast Health Monitoring App Market Recent Trends, In-depth Analysis, Size, and …
According to The Worldwide Market Reports, the Latest research report on "Breast Health Monitoring App Market Size, Revenue, Global Analysis, and Forecast 2023 to 2030" The Breast Health Monitoring App Market research study is a professional report with premium insights into the size of the business, current patterns, drivers, risks, potential outcomes, and major segments. The Industry Report forecasts the future growth of the market based on precise assumptions. Furthermore,
Breast Pumps Market - Nurturing Convenience: Revolutionizing Breast Pump Technol …
Newark, New Castle, USA - new report, titled Breast Pumps Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Breast Pumps market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Breast Pumps market. The report offers an overview of the market, which
Breast Imaging Market by Breast Ultrasound, Breast MRI, Automated Whole-Breast U …
Growth of breast imaging market driven by factors like rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues. Download Free PDF Brochure on Brest Imaging Market Report Now
Breast Implants Market Report 2018: Segmentation by Product (Silicone Breast Imp …
Global Breast Implants market research report provides company profile for Allergan, Mentor Worldwide LLC, Hans biomed, Establishment Labs, Polytech Health & Aesthetics, Sientra, Inc., GC Aesthetics, Cereplas and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to